Fund Details
Trans-Pacific Technology Fund
12F, No.149, Xinyi Rd Sec.3, Taipei City, Da-an District, Taiwan
Overview
Investment portfolio
8rounds
| NAME | DATE | SIZE | |
|---|---|---|---|
Rey.id | Sep 2024Participated | $4 MSeed | |
Rey.id | Jul 2022Participated | $4 MSeed | |
Rey.id | Sep 2021Led | $1 MSeed | |
prixa.ai | Jun 2021Led | $3 MOther Equity | |
Finch Therapeutics | Sep 2020Participated | $90 MSeries D | |
Finch Therapeutics | Aug 2019Participated | $53 MSeries C | |
Heal | May 2018Participated | $20 MOther Equity | |
Kata.ai | Sep 2017Led | $3 MOther Equity | |
Rey.id | Sep 2024Participated | $4 MSeed | |
Rey.id | Jul 2022Participated | $4 MSeed | |
Rey.id | Sep 2021Led | $1 MSeed | |
prixa.ai | Jun 2021Led | $3 MOther Equity | |
Finch Therapeutics | Sep 2020Participated | $90 MSeries D | |
Finch Therapeutics | Aug 2019Participated | $53 MSeries C | |
Heal | May 2018Participated | $20 MOther Equity | |
Kata.ai | Sep 2017Led | $3 MOther Equity |
8 Items
8
Items
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 1 | 2 |
| Series C+ | 0 | 2 |
| Other Equity | 2 | 1 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Sep '17 | 1 |
| Oct '17 | 0 |
| Nov '17 | 0 |
| Dec '17 | 0 |
| Jan '18 | 0 |
| Feb '18 | 0 |
| Mar '18 | 0 |
| Apr '18 | 0 |
| May '18 | 1 |
| Jun '18 | 0 |
| Jul '18 | 0 |
| Aug '18 | 0 |
| Sep '18 | 0 |
| Oct '18 | 0 |
| Nov '18 | 0 |
| Dec '18 | 0 |
| Jan '19 | 0 |
| Feb '19 | 0 |
| Mar '19 | 0 |
| Apr '19 | 0 |
| May '19 | 0 |
| Jun '19 | 0 |
| Jul '19 | 0 |
| Aug '19 | 1 |
| Sep '19 | 0 |
| Oct '19 | 0 |
| Nov '19 | 0 |
| Dec '19 | 0 |
| Jan '20 | 0 |
| Feb '20 | 0 |
| Mar '20 | 0 |
| Apr '20 | 0 |
| May '20 | 0 |
| Jun '20 | 0 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 1 |
| Oct '20 | 0 |
| Nov '20 | 0 |
| Dec '20 | 0 |
| Jan '21 | 0 |
| Feb '21 | 0 |
| Mar '21 | 0 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 1 |
| Jul '21 | 0 |
| Aug '21 | 0 |
| Sep '21 | 1 |
| Oct '21 | 0 |
| Nov '21 | 0 |
| Dec '21 | 0 |
| Jan '22 | 0 |
| Feb '22 | 0 |
| Mar '22 | 0 |
| Apr '22 | 0 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 1 |
| Aug '22 | 0 |
| Sep '22 | 0 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 0 |
| Jan '23 | 0 |
| Feb '23 | 0 |
| Mar '23 | 0 |
| Apr '23 | 0 |
| May '23 | 0 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 0 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 0 |
| Jan '24 | 0 |
| Feb '24 | 0 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 0 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 1 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 0 |
| Jan '25 | 0 |
| Feb '25 | 0 |
| Mar '25 | 0 |
| Apr '25 | 0 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 0 |
| Oct '25 | 0 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 0 |
| Apr '26 | 0 |
| May '26 | 0 |
| Jun '26 | 0 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 7 |
| Fintech | 3 |
| AI & Machine Learning | 3 |
| Enterprise Software | 2 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 5 |
| $5M-$10M | 0 |
| $10M-$25M | 1 |
| $25M-$50M | 0 |
| $50M-$100M | 2 |
| $100M-$250M | 0 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 2 of 2 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| Indonesia | 5 |
| United States | 3 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Avenir | 2 |
| Genesia Ventures | 2 |
| OCV Partners | 2 |
| RDS | 2 |
| Shumway Capital | 2 |
| SymBiosis | 2 |
| Willett Advisors | 2 |
| Arthazen Capital | 1 |
| Bascom Ventures | 1 |
| Baupost Group | 1 |
| CyberAgent Capital | 1 |
| Dell Family Office | 1 |
| Humboldt Fund | 1 |
| Inflection.xyz | 1 |
| IRA Capital | 1 |
| MDI Ventures | 1 |
| Morgan Noble Healthcare Partners | 1 |
| MSD Partners | 1 |
| Octave Group | 1 |
| OMX Ventures | 1 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 3 | 38% |
| Participating | 5 | 63% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 2 | 67% |
| Co-led | 1 | 33% |